We are clearly getting attacked because we're in a weakened position - we have no revenue, and thus no profits - and there's not a strong message as to when those will occur. With no revenue or profits, there is no anchor to any valuation.

And I'm not sure this is BP targeting us. It could be simpler. I could be that there weren't that many stocks that traded down 83% last year (it was a great year for nearly all investments). And we ended up on some type of short-seller screen of big decliners, and they're piling on. Many short sellers i think are momentum traders - often not knowing much about the underlying company.

So how do we fix this? All hands on deck to generate Revenue - and communicate that very clearly and simply out to the market. Forget the other 50 indications for now. Go out to the market with "we are focusing all of our resources and attention on the Q1 BLA submission for HIV. We are highly confident that we will be a revenue producing company in the first half of 2022 (or whatever)." And then just do it.

At the very least, the simplicity of that message may soothe current investors that something certain is close. And it may spook the short-sellers. And even on the low end of our HIV projections (say $500MM in revenue) would raise the market cap significantly. Again, a 6X revenue multiple (typical in biotech) means that $500MM in revenue would equate to a $3 Billion valuation (7X where we are now).